Nutrien (NYSE:NTR) Price Target Raised to $80.00
by Tristan Rich · The Markets DailyNutrien (NYSE:NTR – Get Free Report) had its target price hoisted by equities researchers at Oppenheimer from $78.00 to $80.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s price target suggests a potential upside of 10.80% from the company’s current price.
Other equities research analysts have also issued reports about the company. Weiss Ratings raised Nutrien from a “hold (c)” rating to a “buy (b-)” rating in a research report on Monday, March 2nd. Zacks Research lowered Nutrien from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 2nd. BNP Paribas Exane lowered Nutrien from an “outperform” rating to a “neutral” rating in a research report on Monday, February 23rd. BMO Capital Markets raised their target price on Nutrien from $85.00 to $90.00 and gave the company an “outperform” rating in a research report on Wednesday, March 18th. Finally, JPMorgan Chase & Co. raised their target price on Nutrien from $68.00 to $78.00 and gave the company an “overweight” rating in a research report on Friday, February 20th. Ten research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $80.06.
View Our Latest Analysis on Nutrien
Nutrien Stock Performance
Shares of Nutrien stock traded down $0.47 during trading hours on Wednesday, hitting $72.20. 259,305 shares of the company’s stock traded hands, compared to its average volume of 3,581,421. Nutrien has a 12-month low of $52.34 and a 12-month high of $85.36. The stock has a market capitalization of $34.71 billion, a price-to-earnings ratio of 15.52 and a beta of 0.69. The company has a fifty day simple moving average of $74.58 and a 200-day simple moving average of $65.99. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.34 and a quick ratio of 0.70.
Nutrien (NYSE:NTR – Get Free Report) last announced its earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.87 by ($0.04). Nutrien had a net margin of 8.43% and a return on equity of 8.41%. The business had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same period in the prior year, the business earned $0.31 earnings per share. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year. Equities research analysts anticipate that Nutrien will post 4.69 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in the stock. Guggenheim Capital LLC grew its holdings in Nutrien by 2.2% during the 4th quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock valued at $409,000 after buying an additional 145 shares in the last quarter. Minot DeBlois Advisors LLC grew its holdings in Nutrien by 1.8% during the 4th quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock valued at $557,000 after buying an additional 164 shares in the last quarter. Banque Cantonale Vaudoise grew its holdings in Nutrien by 15.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock valued at $90,000 after buying an additional 164 shares in the last quarter. Smith Moore & CO. grew its holdings in Nutrien by 2.2% during the 3rd quarter. Smith Moore & CO. now owns 7,642 shares of the company’s stock valued at $449,000 after buying an additional 168 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in Nutrien by 21.8% during the 4th quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock valued at $61,000 after buying an additional 176 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.
Nutrien Company Profile
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.